BioNxt Solutions Inc. (OTCMKTS:BNXTF) Short Interest Update

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the recipient of a large drop in short interest during the month of January. As of January 31st, there was short interest totalling 4,100 shares, a drop of 10.9% from the January 15th total of 4,600 shares. Based on an average daily trading volume, of 2,700 shares, the short-interest ratio is currently 1.5 days.

BioNxt Solutions Price Performance

OTCMKTS:BNXTF opened at $0.33 on Monday. The firm’s fifty day moving average price is $0.27 and its 200 day moving average price is $0.21. BioNxt Solutions has a 1-year low of $0.11 and a 1-year high of $0.49. The firm has a market cap of $37.86 million, a price-to-earnings ratio of -8.35 and a beta of 0.69.

BioNxt Solutions (OTCMKTS:BNXTF) last posted its quarterly earnings data on Friday, November 29th. The company reported ($0.01) earnings per share for the quarter.

BioNxt Solutions Company Profile

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.